Soc. Generale Knock-Out PAH3 16.0.../ DE000SW7SQ95 /
30/05/2024 8:12:22 | Diferencia-0.030 | Bid8:28:05 | Ask8:28:05 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
9.180EUR | -0.33% | 9.210 Volumen de oferta: 2,000 |
9.610 Tamaño/ Volumen/ Formato de Ask: 2,000 |
PORSCHE AUTOM.HLDG V... | - EUR | 16/08/2024 | Call |
GlobeNewswire
8:35
Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals
GlobeNewswire
8:30
Samsung Bioepis to Present Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimi...
GlobeNewswire
8:30
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire
8:30
Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area
GlobeNewswire
8:30
Combined General Meeting of June 20, 2024 - Availability of the preparatory documents
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página